---
title: "Salarius Pharmaceuticals (SLRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SLRX.US/norm.md"
symbol: "SLRX.US"
name: "Salarius Pharmaceuticals"
parent: "https://longbridge.com/en/quote/SLRX.US.md"
datetime: "2026-05-21T18:19:40.139Z"
locales:
  - [en](https://longbridge.com/en/quote/SLRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLRX.US/norm.md)
---

# Salarius Pharmaceuticals (SLRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.81 | - | - | - | -11.38 |
| ROE | -204.42% | 997.92% | -869.13% | -263.99% | -146.74% |
| Revenue | - | - | - | - | - |
| Net income | -873467.00 | -957825.00 | -1.71M | -1.46M | -972121.00 |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.10M | 1.39M | 2.34M | 3.02M | 3.86M |
| Leverage | 1.44 | -1.68 | 37.81 | 2.00 | 1.32 |
| BVPS | 4.50 | - | - | - | - |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.65M | -862297.00 | -1.18M | -742518.00 | -1.36M |
| Investing CF | -200000.00 | - | - | - | - |
| Financing CF | 5.86M | -141197.00 | 545566.00 | -106983.00 | 1.37M |
| Free CF | -1.62M | -603152.00 | -117333.00 | -209031.00 | -1.50M |